# Bounded founder reader-growth cycle — September 24, 2026

## Charter and decision

Improve search landing → second founder article → consented newsletter signup → repeat reading. Founder explicitly authorized implementation and conditional publication of PR #286. Moderate risk; release remains conditional on exact-head CI, authenticated preview, editorial verification, review cleanliness, and production certification. No redesign, calculators, generic articles, commercial expansion, account/payment/backend changes, or invented founder experience.

The current founder instruction supersedes the older no-new-work measurement hold only for this bounded cycle and the already-authored PR #286. It does not authorize broader content expansion. Publication-first strategy takes precedence over older platform/product language in the operating documents.

## Current evidence and capability map

- GitHub fetched directly: main `c8b3790`; PR #286 OPEN at `dea381524f3036a5d296e9bff0e05ccab923d064`, ten changed files, two failed checks. Git/gh require the unsandboxed execution context on this Windows host; initial authentication errors were environmental.
- Production fetched directly September 24: homepage is RN-led/publication-first; Newsletter has free medical-bill resources, not the old paid workbook; Tylenol has an article signup, length-of-stay does not; hospital-makes-money returns 404. Public web cache of Newsletter was two months old and is not current-state evidence.
- Code audit: 10 flagships, all with next-step modules and author/methodology attribution; only 3/10 have direct next flagship links in those modules, and 1/10 has a newsletter endcap. Four articles fall back to generic tool/archive cards.
- Existing components: NextStepCards tracks `next_step_click` with source path and destination; NewsletterSignup records submit/error/success with article source and explicit consent. Success means saved subscription, not proven email delivery.
- GitHub Actions repository and Preview/Production environment secret inventories are empty. Current process has no bypass variable. Preview smoke reaches Vercel protection; this is an access failure, not proof of broken canonicals.
- No connected Search Console, subscriber/delivery, or Vercel runtime-log access in this session. Historical September search numbers and the prior conversation are context, not a refreshed baseline. Do not claim zero subscribers, reliable delivery, CTR lift, or repeat readership.
- Local build, Vitest, Playwright, direct HTTP, and official CMS/MACPAC sources are the available verification surfaces. No paid integrations or production configuration changed.

## Implementation and inherited-decision review

| Inherited choice | Evidence/challenge | Disposition |
|---|---|---|
| Tylenol-only signup experiment | Existing capture works; founder now explicitly requests cohort consistency | Expand to 10 flagships; retain original six-page baseline and mark this intervention |
| Tool-first or generic next actions | All ten already have useful modules; missing founder continuation is not missing functionality | Reuse modules, lead with named series next article, retain unique existing utility destinations |
| Newsletter medical-bill module | Now free resources, but competes with publication signup | Remove only from Newsletter; preserve component and other utility surfaces |
| Existing Tylenol title/description | Small historical sample, no current joined query/page/device evidence | Preserve H1, title, description, URL, body and voice; no speculative CTR rewrite |
| Metadata duplication | Newsletter static/prerender and client descriptions differ | Align both existing metadata registries and page copy |
| Preview smoke follows redirects | Login page misdiagnosed as canonical failure; bypass not configured | Explicit protected-access failure, bounded same-origin redirects, credential only to CAF preview HTTPS hosts; never skip the gate |
| Sources substring locator | Matches a second heading containing “resources used” | Exact level-2 heading; keep source visibility assertion |
| FY2026 source described as current until March 2027 review | CMS FY2027 begins October 1 | Date applicability and advance next review to October 1; retain honest publication/review dates |

Two deliberate reading sequences cover hospital money/patient flow and discharge work. Newsletter examples link four existing articles. Author reinforcement uses existing RN/BSN attribution and established lens, not new experience claims. All utility next-step links are retained; no title or body is rewritten for search.

## Quantified impact and anomaly review

| Measure | Before | After implementation | Change |
|---|---:|---:|---:|
| Flagships with next-step module | 10/10 | 10/10 | 0 |
| Flagships with direct next flagship | 3/10 | 10/10 | +7; +70 percentage points |
| Flagships with article newsletter endcap | 1/10 | 10/10 | +9; +90 percentage points |
| Newsletter example articles | 0 | 4 | +4 |
| Growth-cycle routes | 0/192 | 11/192 | 5.7% of candidate canonical inventory |
| Canonical inventory relative to production | 191 | 192 | PR286's one previously authorized article only |
| Ad-eligible routes | 42 | 42 | 0 |

All 10 founder pages change navigation/endcaps, exceeding 20% of that small surface: independently challenged by editorial/user/red-team review. Justified by explicit consistency request, existing component reuse, preserved utility actions, and no body/URL churn. Expected audience benefit is a hypothesis, not demonstrated demand. Additional maintenance is one explicit series registry and regression coverage; no service costs/dependencies. Rollback: normal revert of this release's commits.

## Role quorum and executive accountability

Independent editorial and release specialists reviewed before implementation; remaining implementation/strategy roles were assessed by the coordinating agent. PASS here is scoped to the finding, not an assertion that publication gates passed.

| Role | Executive accountability | Status | Finding / acceptance |
|---|---|---|---|
| Orchestrator | Operations | WARN | Bounded work integrated; publishing requires remaining release evidence |
| Context steward | Operations | PASS | Cached Newsletter evidence rejected; intervention and old/new cohorts recorded |
| Capability router | Technology / operations | WARN | GitHub/current HTTP/local tests available; runtime/search/delivery connectors unavailable |
| Executive strategy | Strategy | PASS | Reader retention advances publication identity without platform expansion |
| Product management | Product | PASS | Minimum journey is next founder read then optional signup |
| Healthcare user research | Clinical/user context | PASS | Immediate patient utility actions retained alongside editorial path |
| Information architecture | Product / discovery | PASS | Two explicit sequences, no new hub/redirect or duplicate destination |
| UX/design system | Product | PASS | Existing cards/forms; no popup or forced signup |
| Content/evidence integrity | Editorial | PASS | CMS/MACPAC claims checked; illustrative example and payment exceptions retained |
| Frontend engineering | Technology | PASS | Typed registry and reused components; cohort/metadata regression tests |
| Systems architecture | Technology | PASS | No backend/dependency/routing architecture change |
| Backend/data/security | Technology / protection | PASS | Bypass restricted to trusted preview origin; no production config change |
| Platform/DevOps | Reliability | BLOCK | Missing Vercel automation bypass credential prevents preview certification |
| SEO/discovery | Marketing/discovery | PASS | Bounded Newsletter description correction; existing ranking-page snippets preserved |
| Monetization/conversion | Finance / revenue | PASS | No monetization expansion; newsletter tied to clear recurring reader value |
| Analytics/experimentation | Data | WARN | Existing consent-aware events reused; actual retained readership/delivery not measured here |
| Accessibility/performance | Accessibility/reliability | WARN | Browser and bundle checks recorded in validation closeout |
| Privacy/legal/user protection | Protection | PASS | No new personal/health fields, fabricated credentials, or coerced subscription |
| Publishing/governance | Editorial / operations | WARN | October 1 payment review explicit; no release while checks blocked |
| Quality/release | Quality/release | BLOCK | Exact-head hosted and authenticated preview checks required |
| Adversarial red team | Red team | WARN | Do not equate saved signup with delivered email or growth with proven demand |
| Process improvement | Process improvement | PASS | Smoke tests now discovered by normal suite; access errors are actionable |

## Primary-source editorial verification

Verified September 24: [CMS IPPS](https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps), [FY2026 tables](https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/fy-2026-ipps-final-rule-home-page), [HRRP](https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp), [HACRP](https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-acquired-condition-reduction-program-hacrp), [Hospital VBP](https://www.cms.gov/medicare/quality/value-based-programs/hospital-purchasing), [OPPS](https://www.cms.gov/cms-guide-medical-technology-companies-and-other-interested-parties/payment/opps), [MACPAC](https://www.macpac.gov/publication/medicaid-base-and-supplemental-payments-to-hospitals/), and [CMS FY2027 effective date](https://www.cms.gov/files/document/r13930cp.pdf). Verification supports existing scoped claims; it does not certify individual clinical or billing decisions.

## Measurement and stopping rule

Owner: Andrew/publisher. Watch second-founder-article clicks per article landing, newsletter submit/save/error by source, actual email delivery and newsletter return clicks, returning readers, and Tylenol CTR by query/page/device with position changes. Existing event definitions remain stable. Consent-related gaps and small samples prevent causal claims. Keep the original six-article cohort, three September care articles, and PR286 separate; annotate actual production date. Review after 28 settled post-release days, or sooner for a broken link/signup/error. No further content/tool work until evidence warrants it.

## Validation and release closeout

- Build PASS: 192 canonical routes/sitemap URLs, 39 redirects, zero search warnings; entry 499.75 KiB under the unchanged 500 KiB limit, largest chunk 550.49 KiB under 600 KiB. Governance, publication, freshness, ad-inventory, API, and boundary gates passed.
- Lint: zero errors, 15 pre-existing fast-refresh warnings.
- Focused article/newsletter tests: 18/18. Protected-deployment smoke regression tests: 16/16, now discovered in standard Vitest via a wrapper.
- Full suite: 801/802 initially passed. The only failure was an untouched SQL fixture checked out as CRLF while an existing assertion expects LF. Restoring Git's original LF bytes locally produced no Git diff; the affected file's 12/12 tests then passed. No payment/database implementation or assertion changed.
- Browser: 32/32 desktop/mobile publication and reader-growth cases passed. Includes all ten flagships, exact Sources headings, canonical metadata, publication/tool regression paths, accessibility, overflow, and a two-article journey into explicit-consent signup. Signup transport was mocked: no real email sent and no delivery claim.
- Known pre-existing development warnings: duplicate text-based React keys in nonprofit table/insurance article paragraphs, Router future flags, old Browserslist data. No new uncaught runtime errors in the exercised journey. No unrelated dependency or body cleanup included.
- Preview: blocked by deployment protection, 0/11 application checks executed successfully; existing credential setting absent. Securely provisioning `VERCEL_AUTOMATION_BYPASS_SECRET` and passing the protected-preview check is an owner/configuration prerequisite; never paste credentials in chat.
- Business validation: PASS for bounded strategic fit; WARN for unproven audience impact, delivery and returning readership. Technical release: BLOCK until current hosted checks and authenticated preview pass. Nothing has been merged/published in this cycle; production-after-merge verification cannot be claimed and remains mandatory.

Compounding assets: explicit series registry, all-flagship journey coverage, actual browser funnel test, smoke credential/redirect regression coverage, and a dated measurement intervention record. Stable strategy context needs no rewrite. CAF-D-026 / CAF-E-023 / CAF-W-023 record this cycle. Next action is preview credential provisioning and exact-head release certification, not further feature expansion.
